Clinical review of cases with parotid tumors

Toshiharu Hirota; Takeshi Matsunobu; Akihiro Kurita; Masayuki Tomifuji; Daisuke Mizokami; Akihiro Shiotani

doi:10.5106/jjshns.18.243

当科における耳下腺腫瘍の臨床統計

廣田稔治, 松延毅, 栗田昭宏, 冨藤雅之, 溝上大輔, 塩谷彰浩

著者情報

キーワード: 耳下腺癌, 穿刺吸引細胞診, 偽陰性, 予後因子

ジャーナルフリー

2008 年 18 巻 3 号 p. 243-250

DOI https://doi.org/10.5106/jjshns.18.243

詳細

発行日: 2009/02/28 受付日: 2008/11/25 J-STAGE公開日: 2011/02/25 受理日: 2009/01/26 早期公開日: - 改訂日: -
訂正情報
訂正日: 2011/02/25 訂正理由: - 訂正箇所: 引用文献情報訂正内容: Wrong : 2) Calearo C, Pastore A, Storchi OF, et al: Parotid gland carcinoma:analysis of prognostic factors. Ann Otol Rhinol Laryngol 107 : 969-973,1998.
3) Seifert G, Sobin LH, World Health Organization International Histological Classification of Tu-mours: Histological Typing of Salivary Gland Tu-mours. 2nded., Berlin, Germany: Springer-Verlag; 1991.
4) Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumours: Pathology and Genetics of the Head and Neck Tumours. Lyon, France: IARC Press; 2005.
9)Berg HM, Jacobs JB, Kaufman D, et al:Correla-tion of fine needle aspiration biopsy and CT scan-ning of parotid masses. Laryngoscope 96:1357-1362,1986.
15) Frankenthaler RA, Luna MA, Lee SS, et al: Prog-nostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 117 :1251-1256, 1991.
16) Zbaren P, Nuyens M, Caversaccio M, et al: Post-operative radiation therapy for T1 and T2 prima-ry parotid carcinoma: Is it useful? Otolaryngolo-gy-Head and Neck Surgery 135:140-143, 2006.
17) Godballe C, Schultz JH, Krogdahl A, et al: Parotid Carcinoma: Impact of Clinical Factors on Progno-sis in a Histologically Revised Series. Laryngo-scope 113 :1411-1417, 2003.
18) Lima RA, Tavares MR, Dias FL, et al: Clinical Prognostic Factors in Malignant Parotid Gland Tumors. Otolaryngology Head Neck 133 : 702-708, 2005.
19) Pohar S, Gay H, Rosenbaum P, et al: Malignant Parotid Tumors: Presentation, Clinical/Pathologic Prognostic Factors, And Treatment Outcomes. Int J Radiation Oncology Biol Phys 61:112-118, 2005.

Right : 2) Calearo C, Pastore A, Storchi OF, et al: Parotid gland carcinoma:analysis of prognostic factors. Ann Otol Rhinol Laryngol 107 : 969-973,1998.
3) Seifert G, Sobin LH, World Health Organization International Histological Classification of Tu-mours: Histological Typing of Salivary Gland Tu-mours. 2nded., Berlin, Germany: Springer-Verlag; 1991.
4) Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumours: Pathology and Genetics of the Head and Neck Tumours. Lyon, France: IARC Press; 2005.
9)Berg HM, Jacobs JB, Kaufman D, et al:Correla-tion of fine needle aspiration biopsy and CT scan-ning of parotid masses. Laryngoscope 96:1357-1362,1986.
15) Frankenthaler RA, Luna MA, Lee SS, et al: Prog-nostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 117 :1251-1256, 1991.
16) Zbaren P, Nuyens M, Caversaccio M, et al: Post-operative radiation therapy for T1 and T2 prima-ry parotid carcinoma: Is it useful? Otolaryngolo-gy-Head and Neck Surgery 135:140-143, 2006.
17) Godballe C, Schultz JH, Krogdahl A, et al: Parotid Carcinoma: Impact of Clinical Factors on Progno-sis in a Histologically Revised Series. Laryngo-scope 113 :1411-1417, 2003.
18) Lima RA, Tavares MR, Dias FL, et al: Clinical Prognostic Factors in Malignant Parotid Gland Tumors. Otolaryngology Head Neck 133 : 702-708, 2005.
19) Pohar S, Gay H, Rosenbaum P, et al: Malignant Parotid Tumors: Presentation, Clinical/Pathologic Prognostic Factors, And Treatment Outcomes. Int J Radiation Oncology Biol Phys 61:112-118, 2005.

抄録

　1991年4月から2008年5月までの約17年間に当科で入院加療を行った耳下腺腫瘍212例について検討した。性別,年齢,組織型,病期分類,術式を提示し,治療法について考察した。また,穿刺吸引細胞診の有用性を検討し,術前診断に穿刺吸引細胞診は有効であるが,偽陰性例もあることから,臨床症状,画像所見,術中迅速病理組織診なども合わせて総合的に判断する必要があると思われた。耳下腺癌は17例を認め,その5年生存率は63.0%であった。予後不良例を検討すると,耳下腺癌患者における予後因子としては,病期,悪性度,術前遠隔転移,術前顔面神経麻痺が重要であると考えられた。

責任著者(Corresponding author)

訂正情報

J-STAGEへの登録はこちら（無料）